Reviewing Guardian Pharmacy Services (NYSE:GRDN) & Stevanato Group (NYSE:STVN)

Stevanato Group (NYSE:STVN) and Guardian Pharmacy Services (NYSE:GRDN) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.

Analyst Recommendations

This is a summary of recent ratings and target prices for Stevanato Group and Guardian Pharmacy Services, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0	2	2	2	3.00
Guardian Pharmacy Services	0	2	7	0	2.78

Guardian Pharmacy Services has a consensus target price of $42.83, suggesting a potential upside of 2.57%. Given Guardian Pharmacy Services’ higher probable upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Stevanato Group.

Earnings & Valuation

This table compares Stevanato Group and Guardian Pharmacy Services”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.20 billion	5.08	$158.21 million	€0.59	34.22
Guardian Pharmacy Services	$1.46 billion	1.43	$49.22 million	$0.83	50.31

Stevanato Group has higher earnings, but lower revenue than Guardian Pharmacy Services. Stevanato Group is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Stevanato Group and Guardian Pharmacy Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Guardian Pharmacy Services	3.64%	30.72%	15.99%

Risk & Volatility

Stevanato Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Guardian Pharmacy Services has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Summary

Guardian Pharmacy Services beats Stevanato Group on 7 of the 13 factors compared between the two stocks.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.